Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-20

Clinical Trial Update: Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the effect of aspirin on abacavir-induced platelet reactivity in HIV-infected patients. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • abacavir (abacavir)

Snippet

Sponsor: Azienda Ospedaliera di Perugia | Conditions: HIV-infected Patients | Phase 2 | Status: COMPLETED